Immune cell triads reprogram exhausted CD8+ T cells for effective tumor elimination

Cancer Cell. 2024 Jul 8;42(7):1152-1154. doi: 10.1016/j.ccell.2024.06.010.

Abstract

In this issue of Cancer Cell, Espinosa-Carrasco et al. show that the efficacy of cancer immunotherapies depends upon the formation of intratumoral immune triads between antigen-presenting cells and antigen-specific CD4+ and CD8+ T cells. This interaction reprograms tumor-specific CD8+ T cells to exert potent effector functions and eradicate established solid tumors.

Publication types

  • Comment

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes* / immunology
  • Humans
  • Immunotherapy / methods
  • Mice
  • Neoplasms* / immunology
  • Neoplasms* / therapy